FRCA Notes


Parenteral Nutrition


  • Where possible, the enteral route should be used in preference to parenteral nutrition
  • In general, the risk outweighs the benefit if PN is provided for <5 days
  • Anticipation of undernutrition (<50% metabolic requirements achieved enterally for >7 days)
  • Severely undernourished patients who will be unable to meet oral requirements prior to surgery, chemotherapy or radiotherapy
  • Patients with gastrointestinal disorders requiring gastrointestinal rest e.g. ulcerative colitis
  • Patients with gastrointestinal disorders precluding normal absorption e.g. short gut syndrome
  • Post-operative patients in whom enteral feeding is not possible (e.g. bowel obstruction) or has failed after 5 days

  • Overall, there isn't a robust evidence bsae suggesting PN is superior to EN for all-comers, and so recommendations for its use are typically for when EN has failed or isn't possible

  • The daily requirements for any given patient will vary, but the estimated requirements can be found on the page on nutritional support
  • The goal of PN is to match these requirements as closely as possible
  • Total parenteral nutrition supplies all daily nutritional requirements to the patient, although other sources of calories may need to be taken into account e.g. propofol infusions, citrate
Nutritional element Notes
Total energy Typically 25-30kcal/kg
Carbohydrate As glucose, with concentration ranging from 40% to 70%
Max. infusion rate 5mg/kg/min
Protein All essential amino acids
Lipid As triglycerides, about 40% non-protein calories
Max. 1.5kg/day
Electrolytes
Vitamins

  • Conditional amino acids
    • Increased demand in critical illness may outstrip synthetic capabilities
    • These are arginine, cysteine, glutamine, tyrosine, glycine, ornithine, proline, and serine
    • Unclear whether supplementation of these conditional amino acids provides benefit
    • Data from some small trials suggests benefit to supplementing glutamine and arginine, but others demonstrate no effect or even harm
    • Routine supplementation is not recommended

  • Vitamins and trace elements are not necessarily contained in PN solutions due to instability
  • They require separate supplementation, including:
    • Mg2+, Ca2+, Cu2+, Zn, Na+, K+, Cl-, Se, Cr, Co, Mn, Fl, I, Mo, V & acetate
    • Vitamins A, C, D, E, K, folate and the B vitamins thiamine, niacin and pyridoxine
  • Evidence does not support administration of doses beyond minimum requirements (SIGNET,  VITdAL-ICU) as it may be harmful

  • Administer through a dedicated port of a central venous catheter including PICC, Hickman and Portacath lines

  • Infusion started at 50% of calculated requirement
  • May require insulin (infusion) to maintain euglycaemia
  • Also a risk of rebound hypoglycaemia once stopped so should be weaned gradually

  • Unless contraindicated, 10 - 30ml/hr of enteral feed should be administered to reduce villous atrophy and maintain gastrointestinal integrity

Related to nutrition

  • Volume overload
  • Nutrient deficiency or excess
  • Glucose abnormalities, especially hyperglycaemia
  • Electrolyte disturbances including refeeding syndrome

  • Metabolic bone disease
    • Demineralisation can occur in long term (>3 months) TPN
    • Remedy is to temporarily or permanently discontinue TPN

  • Hepatobiliary complications
    • Transient LFT derangement is common; cause unknown
    • Delayed or persistent LFT derangement can occur due to excess amino acid levels
    • Cholelithiasis and cholecystitis

Related to central venous catheters

  • Infection is the primary concern
    • The incidence of bacterial or fungal infection is higher in patients who receive PN vs. those who don't

  • Catheter-associated thrombus
  • Thrombophlebitis
  • Complications of insertion e.g. pneumothorax, vascular injury
  • Complications of handling e.g. air embolism, infection